ABD Dermatopathology study plan

Build a decision-tree flowchart that separates the interface dermatitis variants by type of vacuolar change, amount of dyskeratosis, depth and density of the dermal infiltrate, and presence of pigment incontinence.

Sort 40 archived or self-collected inflammatory cases into one of six pattern families - interface, spongiotic, psoriasiform, vesiculobullous, granulomatous, or vasculopathic - and write the pattern label before committing to any diagnosis.

Differentiate the major spongiotic mimics by comparing spongiosis distribution, eosinophil burden, acanthosis regularity, and parakeratosis pattern, and record a single discriminating sentence for each entity.

Explain aloud, without notes, why psoriasiform hyperplasia with regular acanthosis and loss of the granular layer favors psoriasis over chronic spongiotic dermatitis.

Map the direct immunofluorescence patterns of pemphigus vulgaris, bullous pemphigoid, dermatitis herpetiformis, linear IgA disease, and epidermolysis bullosa acquisita by conjugate used, deposit site, and basement-membrane zone versus intercellular location.

Diagram predicted direct immunofluorescence results on salt-split skin for each subepidermal blistering disease and state which side of the split fluoresces and why.

Distinguish leukocytoclastic, lymphocytic, and occlusive vasculopathic patterns by vessel caliber involved, fibrin deposition, nuclear dust, and composition of the infiltrate.

Inventory the granulomatous patterns - tuberculoid, sarcoidal, suppurative, and palisaded - and list the special stains (Fite, periodic acid–Schiff, Gram, silver) needed to exclude infection before calling a process idiopathic.

Construct a criterion-by-criterion comparison of benign, dysplastic, and malignant melanocytic lesions covering symmetry, circumscription, maturation with depth, cytologic atypia grade, and pagetoid scatter height.

Assign a subtype to each melanomas case you review - superficial spreading, nodular, lentigo maligna, acral lentiginous, desmoplastic, or nevoid - and justify the assignment with two histologic features.

Measure Breslow thickness, mitotic rate per square millimeter, and margin status on 30 cases, then verify each measurement against your own written measurement protocol.

Select the minimal immunohistochemical panel that resolves a spindle-cell melanocytic lesion and state what each marker (SRY-related HMG-box 10, Melan-A, human melanoma black 45, Ki-67) adds or fails to add.

Classify lymphoid infiltrates as reactive versus neoplastic using architecture, epidermotropism, cell size and atypia, and the presence or absence of germinal centers or vessel destruction.

Compare the immunohistochemical profiles of the major cutaneous T-cell and B-cell lymphomas, and write the panel you would order first for a dense dermal infiltrate of unknown type.

Separate leukemia cutis, histiocytic proliferations, and mastocytosis from lymphoid mimics by cytomorphology, associated marker expression, and characteristic dermal distribution.

State the indications and limitations of T-cell receptor gene rearrangement studies and immunoglobulin clonality testing in distinguishing reactive from malignant infiltrates.

Differentiate the basal cell carcinoma subtypes and the squamous lesions in the actinic keratosis-to-squamous cell carcinoma sequence by cytology, architecture, stromal reaction, and perineural or lymphovascular involvement.

Contrast seborrheic keratosis and its mimics with true malignant epithelial neoplasms using the features that most often cause overdiagnosis.

Assign a diagnosis to 25 adnexal tumors by matching each to its normal adnexal structure of origin and its dominant histologic clue - horn cysts, ducts, basaloid islands, or stromal retraction.

Identify the histologic features that separate benign adnexal tumors from microcystic adnexal carcinoma and other locally aggressive adnexal carcinomas.

Build a stepwise spindle-cell algorithm that separates dermatofibroma from dermatofibrosarcoma protuberans, and specify the stain that best resolves that specific branch.

Order the vascular tumors by vessel size, architectural growth, cytologic atypia, and marker profile, and state which lesions require human herpesvirus 8 or ERG testing.

Separate the neural and perineural tumors from smooth muscle and fibroblastic tumors by cell shape, stromal background, and a defined three-stain screening panel.

Select first-line versus confirmatory immunostains for five ambiguous soft-tissue scenarios and justify each choice with the expected positive and negative patterns.

Compile a rapid-reference stain table giving, for each of 30 stains, the expected positive pattern, the expected negative pattern, and the most common diagnostic pitfall.

Explain which molecular tests - BRAF and NRAS mutation analysis, TERT promoter sequencing, fluorescence in situ hybridization, and clonality assays - change management in specific cutaneous tumors, and what a negative result does not exclude.

Audit your own earlier diagnoses for staining errors caused by fixation, antigen retrieval, or internal-control failure, and write a short pre-analytic checklist.

Integrate morphology, immunohistochemistry, and molecular results into single-paragraph final reports for ten representative neoplastic cases.

Complete two timed full-length mock examinations under sign-out conditions and score each by domain to expose residual weak areas.

Maintain a structured error log in which every miss is tagged with a cause - pattern misclassification, stain misselection, measurement error, or knowledge gap - and a corrective action.

Re-test every missed item after targeted re-study and confirm that corrected reasoning, not memorized answers, produces the improved score.

Rehearse, out loud, a concise differential for the ten entities you missed most often, ranked by likelihood and supported by one histologic feature each.